[go: up one dir, main page]

CY1116709T1 - POLYMORPHES AND HYPES TOY N- [5- [4- (5 - {[(2R, 6S) -2,6-Dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-Yl] -2- (Methyloxy) -3-Pyridinyl] Methanesulfonamide - Google Patents

POLYMORPHES AND HYPES TOY N- [5- [4- (5 - {[(2R, 6S) -2,6-Dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-Yl] -2- (Methyloxy) -3-Pyridinyl] Methanesulfonamide

Info

Publication number
CY1116709T1
CY1116709T1 CY20151100851T CY151100851T CY1116709T1 CY 1116709 T1 CY1116709 T1 CY 1116709T1 CY 20151100851 T CY20151100851 T CY 20151100851T CY 151100851 T CY151100851 T CY 151100851T CY 1116709 T1 CY1116709 T1 CY 1116709T1
Authority
CY
Cyprus
Prior art keywords
hypes
polymorphes
methyloxy
methanesulfonamide
oxazol
Prior art date
Application number
CY20151100851T
Other languages
Greek (el)
Inventor
Julie Nicole Hamblin
Paul Spencer Jones
Suzanne Elaine Keeling
Joelle Le
Charlotte Jane Mitchell
Nigel James Parr
Robert David Willacy
Original Assignee
Glaxosmithkline Intellectual Property Development Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11755311.5A external-priority patent/EP2614058B1/en
Application filed by Glaxosmithkline Intellectual Property Development Limited filed Critical Glaxosmithkline Intellectual Property Development Limited
Publication of CY1116709T1 publication Critical patent/CY1116709T1/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση κατευθύνεται σε νέα πολύμορφα και άλατα μιας ένωσης η οποία είναι αναστολέας δραστικότητας κινάσης.The present invention is directed to novel polymorphs and salts of a compound which is a kinase activity inhibitor.

CY20151100851T 2010-09-08 2015-09-28 POLYMORPHES AND HYPES TOY N- [5- [4- (5 - {[(2R, 6S) -2,6-Dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-Yl] -2- (Methyloxy) -3-Pyridinyl] Methanesulfonamide CY1116709T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38074810A 2010-09-08 2010-09-08
EP11755311.5A EP2614058B1 (en) 2010-09-08 2011-09-06 POLYMORPHS AND SALTS OF N-[5-[4-(5-{[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]METHYL}-& xA;1,3-OXAZOL-2-YL)-1H-INDAZOL-6-YL]-2-(METHYLOXY)-3-PYRIDINYL]METHANESULFONAMIDE

Publications (1)

Publication Number Publication Date
CY1116709T1 true CY1116709T1 (en) 2017-03-15

Family

ID=58459815

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100851T CY1116709T1 (en) 2010-09-08 2015-09-28 POLYMORPHES AND HYPES TOY N- [5- [4- (5 - {[(2R, 6S) -2,6-Dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-Yl] -2- (Methyloxy) -3-Pyridinyl] Methanesulfonamide

Country Status (1)

Country Link
CY (1) CY1116709T1 (en)

Similar Documents

Publication Publication Date Title
SMT201500223B (en) Polymorphs and salts of n- [5- [4- (5 - {[(2R, 6S) -2,6-dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazol -6-IL] -2- (methyloxy) -3-piridinilÜmetansolfonammide
FR23C1050I2 (en) COMPOUND OF 3,5-DISUBSTITUTED ALKYNYLBENZENE AND A SALT THEREOF
EA201490543A1 (en) Derivatives of Bicyclic Heterocycles for the Treatment of Pulmonary Arterial Hypertension
JO3025B1 (en) Oxazole substituted andazole as PI3 inhibitors
EA201700230A1 (en) DETERMINED AMINOPYRIDINES, COMPOSITIONS ON THEIR BASIS AND METHODS OF THEIR APPLICATION
CY1117218T1 (en) 6-fluoro-3-hydroxy-2-pyrazine carbamide salt of meglumine
BRPI0920598A2 (en) solid forms of n- (4- (7-azabicyclo [2.2.1] heptan-7-yl) -2- (trifluoromethyl) phenyl) -4-oxo-5- (trifluoromethyl) -1,4-di -hydroquinoline-3-carboxamide
CY1121248T1 (en) POLYMORPHIC FORMS AND SALTS 6- (1H-INDOL-4-YL) -4- (5 - {[4- (1-METHYLETHYL) -1-PIPERAZINYL] METHYL} -1,3-OXAZOL-1-Y -INDAZOLIE AS RI3K INHIBITORS FOR USE IN THERAPY BC RESPIRATORY DISORDERS
ATE552255T1 (en) 4-AMINOINDAZOLES
EA201591503A1 (en) NAFTHYRIDINE DERIVATIVES, USEFUL AS ANTAGONISTS ALPHA-V-BETA-6 INTEGRINA
PE20151667A1 (en) HISTONE DESMETILASE INHIBITORS
BRPI0815048B8 (en) phenoxy-pyrrolidine derivatives, their uses and pharmaceutical compositions
EA201270149A1 (en) BACE INHIBITORS
CL2013000104A1 (en) Compounds derived from substituted nitrogen heterocyclics, ip receptor agonists; pharmaceutical composition; pharmaceutical combination; and use for the treatment of pulmonary arterial hypertension.
EA201492255A1 (en) PHENOXYETHYLPIPERIDINE COMPOUNDS
AR094935A1 (en) N-HYDROXI-4- TOSILATE {2- [3- (N, N-DIMETHYLAMINOME) BENZOFURAN-2-ILCARBONIL-AMINO] ETOXI} BENZAMIDA (ABEXINOSTAT)
EA201590621A1 (en) AGGRECANASE INHIBITORS
MX2019007327A (en) Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]et hoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof.
EA201170828A1 (en) CONDENSED HETEROCYCLIC DERIVATIVES OF OXADIAZOL, SUITABLE FOR THE TREATMENT OF SCATTERED SCLEROSIS
EA201400475A1 (en) METHODS OF OBTAINING NEW DERIVATIVES OF BENZIMIDAZOLE
CL2013003068A1 (en) Compounds derived from 2- (ethynyl-pyridin-2-yl) -pyrazolidin-3-one, 2- (ethynyl-pyrimidin-2-yl) -pyrazolidin-3-one or 2- (ethynyl-pyridazin-3-yl) -pyrazzolidin-3-one; mglur5 positive allosteric modulators; preparation procedure; pharmaceutical composition; and its use to treat schizophrenia or cognitive diseases.
CY1113845T1 (en) DIVENZOTHEIAZEPIN PRODUCTION AND USE OF IT
EA201491227A1 (en) NEW MORFOLINIL DERIVATIVES SUITABLE FOR USING AS MOGAT-2 INHIBITORS
EA201691331A1 (en) METHOD OF OBTAINING ORGANIC COMPOUNDS
EA201391744A1 (en) DERIVATIVES 2-AMINO-3- (IMIDAZOL-2-IL) -PYRIDIN-4-SHE AND THEIR APPLICATION AS KINASE RECEPTOR KINASE INHIBITORS